General MedicationsORALGeneric

PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE

Standard Dose

25MG;40MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 072043 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE Form and strength TABLET;ORAL - 25MG;40MG Sponsor ANI PHARMS Submission history Latest submission status date: 2020-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 072043 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE Form and strength TABLET;ORAL - 25MG;40MG Sponsor ANI PHARMS Submission history Latest submission status date: 2020-08-20 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.